BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 21874597)

  • 1. Novel approaches to treating leptomeningeal metastases.
    Grewal J; Saria MG; Kesari S
    J Neurooncol; 2012 Jan; 106(2):225-34. PubMed ID: 21874597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptomeningeal Metastases in Melanoma Patients: An Update on and Future Perspectives for Diagnosis and Treatment.
    Steininger J; Gellrich FF; Engellandt K; Meinhardt M; Westphal D; Beissert S; Meier F; Glitza Oliva IC
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Aneuploidy in Cerebrospinal Fluid from Patients with Breast Cancer Can Improve Diagnosis of Leptomeningeal Metastases.
    Angus L; Deger T; Jager A; Martens JWM; de Weerd V; van Heuvel I; van den Bent MJ; Sillevis Smitt PAE; Kros JM; Bindels EMJ; Heitzer E; Sleijfer S; Jongen JLM; Wilting SM
    Clin Cancer Res; 2021 May; 27(10):2798-2806. PubMed ID: 33514525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptomeningeal disease.
    Groves MD
    Neurosurg Clin N Am; 2011 Jan; 22(1):67-78, vii. PubMed ID: 21109151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningeal carcinomatosis in solid tumors.
    Martins SJ; Azevedo CR; Chinen LT; Cruz MR; Peterlevitz MA; Gimenes DL
    Arq Neuropsiquiatr; 2011 Dec; 69(6):973-80. PubMed ID: 22297890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer avenues for the treatment of leptomeningeal carcinomatosis.
    Meriggi F; Zaniboni A
    Cent Nerv Syst Agents Med Chem; 2011 Mar; 11(1):38-44. PubMed ID: 21250935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of leptomeningeal metastasis in breast cancer.
    Assi HI; Mahmoud T; Saadeh FS; El Darsa H
    Clin Neurol Neurosurg; 2018 Sep; 172():151-159. PubMed ID: 30015053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe.
    Le Rhun E; Rudà R; Devos P; Hoang-Xuan K; Brandsma D; Pérez Segura P; Soffietti R; Weller M
    J Neurooncol; 2017 Jun; 133(2):419-427. PubMed ID: 28455788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptomeningeal Metastasis: A Review of the Pathophysiology, Diagnostic Methodology, and Therapeutic Landscape.
    Nguyen A; Nguyen A; Dada OT; Desai PD; Ricci JC; Godbole NB; Pierre K; Lucke-Wold B
    Curr Oncol; 2023 Jun; 30(6):5906-5931. PubMed ID: 37366925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare case of pancreatic cancer with leptomeningeal carcinomatosis.
    Yoo IK; Lee HS; Kim CD; Chun HJ; Jeen YT; Keum B; Kim ES; Choi HS; Lee JM; Kim SH; Nam SJ; Hyun JJ
    World J Gastroenterol; 2015 Jan; 21(3):1020-3. PubMed ID: 25624740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of metastatic leptomeningeal carcinomatosis from early gastric carcinoma.
    Park KK; Yang SI; Seo KW; Kim YO; Yoon KY
    World J Surg Oncol; 2012 May; 10():74. PubMed ID: 22553956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Known and emerging biomarkers of leptomeningeal metastasis and its response to treatment.
    Walbert T; Groves MD
    Future Oncol; 2010 Feb; 6(2):287-97. PubMed ID: 20146587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptomeningeal metastasis from systemic cancer: Review and update on management.
    Wang N; Bertalan MS; Brastianos PK
    Cancer; 2018 Jan; 124(1):21-35. PubMed ID: 29165794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytopathological differential diagnosis of malignant tumor cells in the cerebrospinal fluid: A retrospective analysis.
    Ruotolo R; Maffei E; Sabbatino F; Serio B; Zeppa P; Caputo A
    Diagn Cytopathol; 2023 Dec; 51(12):751-757. PubMed ID: 37638606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel methods to diagnose leptomeningeal metastases in breast cancer.
    Angus L; Martens JWM; van den Bent MJ; Sillevis Smitt PAE; Sleijfer S; Jager A
    Neuro Oncol; 2019 Mar; 21(4):428-439. PubMed ID: 30418595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leveraging Molecular and Immune-Based Therapies in Leptomeningeal Metastases.
    Wilcox JA; Boire AA
    CNS Drugs; 2023 Jan; 37(1):45-67. PubMed ID: 36474108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of leptomeningeal carcinomatosis and challenges of trial design.
    Gill CM; Brastianos PK
    Curr Opin Oncol; 2019 Nov; 31(6):508-513. PubMed ID: 31503030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptomeningeal Carcinomatosis: Molecular Landscape, Current Management, and Emerging Therapies.
    Bhambhvani HP; Rodrigues AJ; Umeh-Garcia MC; Hayden Gephart M
    Neurosurg Clin N Am; 2020 Oct; 31(4):613-625. PubMed ID: 32921356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The necessity of intrathecal chemotherapy for the treatment of breast cancer patients with leptomeningeal metastasis: A systematic review and pooled analysis.
    Lee YC; Hsieh CC; Chuang JP; Li CY
    Curr Probl Cancer; 2017; 41(5):355-370. PubMed ID: 28779849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptomeningeal metastasis from systemic cancer.
    Clarke JL
    Continuum (Minneap Minn); 2012 Apr; 18(2):328-42. PubMed ID: 22810130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.